Clark Capital Management Group, Inc.

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1352187 PHILADELPHIA, PA

Position in VRTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$217,464

-$22,816 QoQ

Shares Held

487

-8.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Clark Capital Management Group, Inc. holds $130,946,596 across 6 Biotechnology names. VRTX ranks #6 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	1,639,968	$78,669,264
2	LGND	Ligand Pharmaceuticals Inc	90,206	$18,009,627
3	CPRX	Catalyst Pharmaceuticals, Inc.	568,676	$14,080,417
4	HALO	Halozyme Therapeutics, Inc.	214,102	$13,837,412
5	EXEL	Exelixis, Inc.	142,980	$6,132,412
6	VRTX	Vertex Pharmaceuticals Inc / Ma This page	487	$217,464

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$217,464	487	-8.1%	Shares	Sole	2026-05-15
2025-12-31	$240,280	530	-7.3%	Shares	Sole	2026-02-17
2025-09-30	$224,018	572	+18.9%	Shares	Sole	2025-11-14
2025-06-30	$214,141	481	-2.4%	Shares	Sole	2025-08-14
2025-03-31	$239,016	493	-8.7%	Shares	Sole	2025-05-15
2024-12-31	$217,458	540	-10.4%	Shares	Sole	2025-02-14
2024-09-30	$280,443	603	+11.9%	Shares	Sole	2024-11-14
2024-06-30	$252,640	539	-60.0%	Shares	Sole	2024-08-14
2021-03-31	$289,241	1,346	+56.3%	Shares	Sole	2021-05-17
2020-12-31	$203,488	861	0.0%	Shares	Sole	2021-01-26
2020-09-30	$234,295	861	+1.2%	Shares	Sole	2020-11-12
2020-06-30	$247,053	851	-40.2%	Shares	Sole	2020-08-14
2020-03-31	$338,840	1,424	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.